Literature DB >> 7591426

Evolving role of nondermatophytes in onychomycosis.

D L Greer1.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7591426     DOI: 10.1111/j.1365-4362.1995.tb02942.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  14 in total

1.  Current Management of Onychomycosis and Dermatomycoses.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi.

Authors:  A K Gupta; E A Cooper; P MacDonald; R C Summerbell
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents.

Authors:  Zulal Erbagci; Almila Tuncel; Yasemin Zer; Iclal Balci
Journal:  Mycopathologia       Date:  2005-04       Impact factor: 2.574

Review 4.  An overview of fungal infections.

Authors:  G Garber
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Fusarium nail and skin infection: a report of eight cases from Natal, Brazil.

Authors:  Nicácia Barbosa Calado; Francisco Sousa; Nadja Oliveira Gomes; Fernando Ramos Cardoso; Luis Conrado Zaror; Eveline Pipolo Milan
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

6.  A new model of in vitro fungal biofilms formed on human nail fragments allows reliable testing of laser and light therapies against onychomycosis.

Authors:  Taissa Vieira Machado Vila; Sonia Rozental; Claudia Maria Duarte de Sá Guimarães
Journal:  Lasers Med Sci       Date:  2014-12-04       Impact factor: 3.161

7.  Nondermatophytic moulds as a causative agent of onychomycosis in tehran.

Authors:  Shahindokht Bassiri-Jahromi; Ali Asgar Khaksar
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

8.  Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.

Authors:  William J Jo Siu; Yoshiyuki Tatsumi; Hisato Senda; Radhakrishnan Pillai; Takashi Nakamura; Daisuke Sone; Annette Fothergill
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

Review 9.  The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

10.  Onychomycosis in qassim region of saudi arabia: a clinicoaetiologic correlation.

Authors:  Muhammad Shahzad; Abdullateef A Alzolibani; Ahmad A Al Robaee; Ghada A Bin Saif; Ibrahim H K Babikir; Eltuhami M Abdel-Magied; Abeer E Elsayed
Journal:  J Clin Diagn Res       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.